\-\ Texto\\:\\ \ \(0\)\
\-\ the\\ patient\\ was\\ admitted\\ to\\ the\\ hospital\\,\\ where\\ she\\ initially\\ received\\ serial\\ head\\ ct\\'s\\ to\\ monitor\\ for\\ progression\\/evolution\\ of\\ her\\ hemorrhage\\ \\(there\\ was\\ no\\ progression\\)\\.\\ \\ she\\ subsequently\\ received\\ an\\ mri\\/mra\\ of\\ the\\ brain\\ \\(normal\\ mra\\)\\,\\ followed\\ by\\ a\\ carotid\\ ultrasound\\.\\ \\ the\\ ultrasound\\ revealed\\ atherosclerotic\\ plaque\\ without\\ hemodynamically\\ significant\\ stenosis\\.\ \(0\)\
\-\ approximately\\ three\\ weeks\\ after\\ admission\\ the\\ patient\\ was\\ discharged\\ with\\ some\\ persistent\\ weakness\\ and\\ scheduled\\ for\\ outpatient\\ rehabilitation\\ therapy\\.\ \(0\)\
\-\ \\â\\€\\¢\\ acute\\ ct\\ \\(obtained\\ within\\ hours\\ of\\ symptom\\ onset\\)\\:\\ \\ hyperattenuating\\ lesion\\ in\\ right\\ putamen\\ with\\ surrounding\\ hypodensity\\ consistent\\ with\\ edema\\.\\ \\ mass\\ effect\\ on\\ the\\ adjacent\\ lateral\\ ventricle\\ and\\ effacement\\ of\\ the\\ nearby\\ sulci\\ is\\ noted\\.\ \(0\)\
\-\ \\â\\€\\¢\\ followup\\ mri\\ \\(obtained\\ 6\\ days\\ after\\ symptom\\ onset\\)\\:\\ \\ right\\ putamen\\ lesion\\ with\\ a\\ rim\\ of\\ t1\\ bright\\,\\ t2\\ dark\\ signal\\ intensity\\.\\ \\ surrounding\\ t2\\ bright\\ signal\\ consistent\\ with\\ edema\\.\\ \\ no\\ enhancement\\ \\(compare\\ pre\\-\\ and\\ post\\-gd\\ images\\)\\.\ \(0\)\
\-\ hypertensive\\ basal\\ ganglia\\ hemorrhage\ \(0\)\
\-\ hemorrhagic\\ lesion\\ in\\ putamen\\ \\â\\€\\“\\ differential\\ includes\\:\ \(0\)\
\-\ \\â\\€\\¢\\ hypertensive\\ hemorrhage\ \(1\)\
\-\ \\â\\€\\¢\\ hemorrhage\\ from\\ a\\ vascular\\ malformation\ \(1\)\
\-\ \\â\\€\\¢\\ hemorrhage\\ from\\ a\\ neoplasm\\ \\(primary\\ or\\ metastatic\\)\ \(1\)\
\-\ 81\\ y\\.o\\.\\ woman\\ presents\\ to\\ the\\ emergency\\ department\\ with\\ left\\ sided\\ weakness\\ and\\ a\\ systolic\\ blood\\ pressure\\ of\\ 200mm\\ hg\\.\ \(0\)\
\-\ the\\ t1\\-bright\\,\\ t2\\-dark\\ rim\\ classifies\\ the\\ stroke\\ in\\ the\\ early\\ subacute\\ phase\\ of\\ hemoglobin\\ breakdown\\ \\(within\\ 3\\ to\\ 7\\ days\\)\\.\\ this\\ is\\ consistent\\ with\\ the\\ fact\\ that\\ the\\ mri\\ was\\ obtained\\ 6\\ days\\ after\\ the\\ ictus\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ putamen\\:\\ 0\\.0718193150505958\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.05512125163131852\ \(0\)\
\-\ hypertensive\\:\\ 0\\.03918076207963516\ \(0\)\
\-\ symptom\\:\\ 0\\.037559895429568814\ \(0\)\
\-\ obtained\\:\\ 0\\.03532402442725398\ \(0\)\
\-\ progression\\/evolution\\:\\ 0\\.03416867606188565\ \(0\)\
\-\ post\\-gd\\:\\ 0\\.03416867606188565\ \(0\)\
\-\ 200mm\\:\\ 0\\.03416867606188565\ \(0\)\
\-\ classifies\\:\\ 0\\.03416867606188565\ \(0\)\
\-\ bright\\:\\ 0\\.033118012726329416\ \(0\)\
\-\ t2\\-dark\\:\\ 0\\.03148205908297114\ \(0\)\
\-\ ictus\\:\\ 0\\.03148205908297114\ \(0\)\
\-\ received\\:\\ 0\\.03078551424424734\ \(0\)\
\-\ days\\:\\ 0\\.030454352281069505\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.030368495185966817\ \(0\)\
\-\ t1\\-bright\\:\\ 0\\.02879544210405662\ \(0\)\
\-\ rim\\:\\ 0\\.028038925524811416\ \(0\)\
\-\ compare\\:\\ 0\\.0261088251251421\ \(0\)\
\-\ mri\\/mra\\:\\ 0\\.02524392763942811\ \(0\)\
\-\ weakness\\:\\ 0\\.02460163839556887\ \(0\)\
\-\ pre\\-\\:\\ 0\\.024537254938676346\ \(0\)\
\-\ consistent\\:\\ 0\\.02436393335850236\ \(0\)\
\-\ nearby\\:\\ 0\\.024227011885678145\ \(0\)\
\-\ hyperattenuating\\:\\ 0\\.023939771683531934\ \(0\)\
\-\ breakdown\\:\\ 0\\.023939771683531934\ \(0\)\
\-\ hg\\:\\ 0\\.022965684752210596\ \(0\)\
\-\ rehabilitation\\:\\ 0\\.021850637959761828\ \(0\)\
\-\ surrounding\\:\\ 0\\.02177647491755632\ \(0\)\
\-\ 81\\:\\ 0\\.021540394906763627\ \(0\)\
\-\ hemodynamically\\:\\ 0\\.021394114565744842\ \(0\)\
\-\ onset\\:\\ 0\\.020910242061435273\ \(0\)\
\-\ after\\:\\ 0\\.020558153518711656\ \(0\)\
\-\ hypodensity\\:\\ 0\\.020388257218903427\ \(0\)\
\-\ lesion\\:\\ 0\\.02023901425581924\ \(0\)\
\-\ hemoglobin\\:\\ 0\\.02017287019892354\ \(0\)\
\-\ plaque\\:\\ 0\\.019968824720297877\ \(0\)\
\-\ atherosclerotic\\:\\ 0\\.019870693681599074\ \(0\)\
\-\ 6\\:\\ 0\\.019783877219960267\ \(0\)\
\-\ ultrasound\\:\\ 0\\.019652113062064366\ \(0\)\
\-\ \\(\\:\\ 0\\.019598961564755907\ \(0\)\
\-\ \\)\\:\\ 0\\.019359549786019906\ \(0\)\
\-\ sulci\\:\\ 0\\.018929041826520047\ \(0\)\
\-\ monitor\\:\\ 0\\.01885377792784911\ \(0\)\
\-\ outpatient\\:\\ 0\\.01885377792784911\ \(0\)\
\-\ t2\\:\\ 0\\.018748750145351566\ \(0\)\
\-\ edema\\:\\ 0\\.01873584100334334\ \(0\)\
\-\ she\\:\\ 0\\.01859524140662149\ \(0\)\
\-\ mra\\:\\ 0\\.0185665377257029\ \(0\)\
\-\ systolic\\:\\ 0\\.018430524858217362\ \(0\)\
\-\ effacement\\:\\ 0\\.018172031158610102\ \(0\)\
\-\ dark\\:\\ 0\\.018110014331685912\ \(0\)\
\-\ signal\\:\\ 0\\.017465692482734718\ \(0\)\
\-\ fact\\:\\ 0\\.017434226009419334\ \(0\)\
\-\ stroke\\:\\ 0\\.01728220774138336\ \(0\)\
\-\ subacute\\:\\ 0\\.016994967539237148\ \(0\)\
\-\ ganglia\\:\\ 0\\.016949097548357293\ \(0\)\
\-\ scheduled\\:\\ 0\\.016684724486238946\ \(0\)\
\-\ serial\\:\\ 0\\.01651799043552697\ \(0\)\
\-\ progression\\:\\ 0\\.0164774040019328\ \(0\)\
\-\ followup\\:\\ 0\\.015811317734775204\ \(0\)\
\-\ phase\\:\\ 0\\.015580340613836266\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.015454281731256578\ \(0\)\
\-\ was\\:\\ 0\\.015322132127343981\ \(0\)\
\-\ mri\\:\\ 0\\.015219192673756743\ \(0\)\
\-\ discharged\\:\\ 0\\.015184800868277467\ \(0\)\
\-\ basal\\:\\ 0\\.015098982550923927\ \(0\)\
\-\ subsequently\\:\\ 0\\.015015023261074395\ \(0\)\
\-\ \\â\\€\\“\\:\\ 0\\.014905833815467045\ \(0\)\
\-\ carotid\\:\\ 0\\.014852371326582023\ \(0\)\
\-\ department\\:\\ 0\\.014852371326582023\ \(0\)\
\-\ admission\\:\\ 0\\.014595590762468842\ \(0\)\
\-\ admitted\\:\\ 0\\.014308350560322631\ \(0\)\
\-\ where\\:\\ 0\\.013517993237119833\ \(0\)\
\-\ initially\\:\\ 0\\.013480543970020077\ \(0\)\
\-\ includes\\:\\ 0\\.013352249596274556\ \(0\)\
\-\ persistent\\:\\ 0\\.013210645939947207\ \(0\)\
\-\ malformation\\:\\ 0\\.013210645939947207\ \(0\)\
\-\ \\:\\:\\ 0\\.013142730418496104\ \(0\)\
\-\ hours\\:\\ 0\\.013024020576003088\ \(0\)\
\-\ pressure\\:\\ 0\\.0130074918985362\ \(0\)\
\-\ stenosis\\:\\ 0\\.01297464450709832\ \(0\)\
\-\ 7\\:\\ 0\\.012690910382977023\ \(0\)\
\-\ within\\:\\ 0\\.01263667758438823\ \(0\)\
\-\ emergency\\:\\ 0\\.012541816271241379\ \(0\)\
\-\ hospital\\:\\ 0\\.0124693661432873\ \(0\)\
\-\ ventricle\\:\\ 0\\.01241236557200941\ \(0\)\
\-\ sided\\:\\ 0\\.012246227182738935\ \(0\)\
\-\ early\\:\\ 0\\.01211301926217999\ \(0\)\
\-\ intensity\\:\\ 0\\.01197159176891202\ \(0\)\
\-\ effect\\:\\ 0\\.011726969973136608\ \(0\)\
\-\ neoplasm\\:\\ 0\\.011279676650821427\ \(0\)\
\-\ three\\:\\ 0\\.011165210187391125\ \(0\)\
\-\ followed\\:\\ 0\\.011104170044103766\ \(0\)\
\-\ vascular\\:\\ 0\\.010859702588851538\ \(0\)\
\-\ revealed\\:\\ 0\\.010629743759170904\ \(0\)\
\-\ differential\\:\\ 0\\.01051534817578655\ \(0\)\
\-\ t1\\:\\ 0\\.010498044714047456\ \(0\)\
\-\ adjacent\\:\\ 0\\.010472233504396385\ \(0\)\
\-\ approximately\\:\\ 0\\.010247355916882105\ \(0\)\
\-\ some\\:\\ 0\\.010057861449095965\ \(0\)\
\-\ brain\\:\\ 0\\.009966478772491325\ \(0\)\
\-\ her\\:\\ 0\\.009958959916608277\ \(0\)\
\-\ from\\:\\ 0\\.009817331109722577\ \(0\)\
\-\ primary\\:\\ 0\\.009811566910448436\ \(0\)\
\-\ y\\.o\\:\\ 0\\.009559610203824419\ \(0\)\
\-\ weeks\\:\\ 0\\.009400301383337785\ \(0\)\
\-\ head\\:\\ 0\\.009393803529356187\ \(0\)\
\-\ ct\\:\\ 0\\.009265919793736766\ \(0\)\
\-\ blood\\:\\ 0\\.009040352994222092\ \(0\)\
\-\ significant\\:\\ 0\\.008906384306411719\ \(0\)\
\-\ enhancement\\:\\ 0\\.00887786343458541\ \(0\)\
\-\ therapy\\:\\ 0\\.008855196884653539\ \(0\)\
\-\ metastatic\\:\\ 0\\.008337633347349186\ \(0\)\
\-\ acute\\:\\ 0\\.00817782685700192\ \(0\)\
\-\ noted\\:\\ 0\\.007850469722684472\ \(0\)\
\-\ without\\:\\ 0\\.007798500644799071\ \(0\)\
\-\ 3\\:\\ 0\\.007755719095761782\ \(0\)\
\-\ a\\:\\ 0\\.007686042670903125\ \(0\)\
\-\ woman\\:\\ 0\\.007650786618174055\ \(0\)\
\-\ the\\:\\ 0\\.0075018991699641905\ \(0\)\
\-\ \\'s\\:\\ 0\\.007302506272740484\ \(0\)\
\-\ lateral\\:\\ 0\\.007157628083816086\ \(0\)\
\-\ right\\:\\ 0\\.006989393093879199\ \(0\)\
\-\ presents\\:\\ 0\\.006766063160883433\ \(0\)\
\-\ no\\:\\ 0\\.00667010969537831\ \(0\)\
\-\ patient\\:\\ 0\\.006640247526483628\ \(0\)\
\-\ to\\:\\ 0\\.00662121098361219\ \(0\)\
\-\ images\\:\\ 0\\.006353736015307574\ \(0\)\
\-\ that\\:\\ 0\\.005720855537049703\ \(0\)\
\-\ for\\:\\ 0\\.005652001152269109\ \(0\)\
\-\ by\\:\\ 0\\.005515003500949127\ \(0\)\
\-\ normal\\:\\ 0\\.00519229633565543\ \(0\)\
\-\ there\\:\\ 0\\.004929130063817786\ \(0\)\
\-\ in\\:\\ 0\\.0048999677923285455\ \(0\)\
\-\ mass\\:\\ 0\\.0046064380114246685\ \(0\)\
\-\ an\\:\\ 0\\.004580096373196627\ \(0\)\
\-\ is\\:\\ 0\\.004358843243292446\ \(0\)\
\-\ \\,\\:\\ 0\\.004197055279337789\ \(0\)\
\-\ or\\:\\ 0\\.0038818711200143702\ \(0\)\
\-\ this\\:\\ 0\\.0037253380361012907\ \(0\)\
\-\ left\\:\\ 0\\.003705834377026801\ \(0\)\
\-\ with\\:\\ 0\\.003174531909415613\ \(0\)\
\-\ of\\:\\ 0\\.003160955835604337\ \(0\)\
\-\ on\\:\\ 0\\.0028057791176954575\ \(0\)\
\-\ and\\:\\ 0\\.0027908372981739296\ \(0\)\
\-\ \\.\\:\\ 0\\.0017887363149825643\ \(0\)\
